+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 0Years +
All Genders
ID05778006

German Multi-Center Registry for MECFS Including Cases After EBV Infection or COVID-19

Led by Technical University of Munich · Updated on 2025-01-10

650

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are gathering data in Germany to better understand MECFS, a chronic disease that can cause severe disability and affects people of all ages, especially adolescents and young adults. The study focuses on MECFS caused by infections like COVID-19 and Epstein-Barr virus. It aims to identify disease patterns, subtypes, and patient experiences to support future clinical trials and improve care. This is a web-based registry study collecting detailed medical histories, physical examination results, laboratory and technical test findings, and patient journey information over 30 years. Participants may also provide biosamples to aid future research. The study does not involve treatments but gathers comprehensive clinical data to describe the disease and its progression. Participants will share their medical history and undergo routine examinations and tests. Researchers will track symptoms, lab results, and other assessments to identify abnormal findings and related health conditions. The study also evaluates patient experiences and aims to find markers that may predict disease course. Participation involves data collection and possible biosample donations, with long-term observation planned up to 30 years.

CONDITIONS

Brief Title

Multi-Center Registry for ME/CFS

Research Team

U

Uta Behrends, Prof. Dr. med.

D

Daniela Schindler, Dr.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here